NEWS

Catalyst OrthoScience has raised $12.7 million in an oversubscribed Series C-1 financing round led by River Cities Capital Funds.

Catalyst OrthoScience announced 510(k) clearance for its uncemented Press Fit humeral implant. The new humeral

Catalyst OrthoScience introduced the patent pending 3-Peg Glenoid implant to its innovative Catalyst CSR™ Total Shoulder

Catalyst OrthoScience was granted four new patents by the United States Patent and Trademark Office for technologies incorporated in the CSR™ Total Shoulder System. Catalyst OrthoScience, Inc. has been granted four new patents by the United States Patent and Trademark Office for technologies incorporated in the CSR™ Total Shoulder Replacement…

Catalyst OrthoScience, Inc., a cutting-edge medical device company focused on the upper extremity orthopedics market, today announced the addition of Greg Rainey to its Board of Directors. Mr. Rainey brings over forty years of experience to the Catalyst OrthoScience Board. Mr. Rainey's career has been in sales management and business…

A Naples-based company took the top prize at the VentureTech Showcase in Tampa. Catalyst OrthoScience LLC, which has developed what it describes as a "breakthrough product" for shoulder-replacement surgery, beat out 13 other contenders to be crowned the "best growth stage" company in Florida. The grand prize award came with a check…

A Naples-based investment fund has bet its money on the success of a local orthopedic medical device startup. The fund, Tamiami Angel Fund II, or T2 for short, has invested nearly $1 million in Catalyst OrthoScience to help the company ramp up the production of what it describes as a…